I-Mab (NASDAQ:IMAB) Q2 2024 Earnings Call Transcript
Operator: Greetings. Welcome to I-MAB Biopharma’s first half 2024 financial results and corporate update conference call. At this time, all participants are in listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Hillhouse Capital Management Lei Zhang | 6,909,220 | $8,567,433 | 0.18% | |
2. | Two Sigma Advisors John Overdeck And David Siegel | 499,300 | $619,132 | -14% | 0% |
3. | Citadel Investment Group Ken Griffin | 98,389 | $122,002 | +155% | 0% |
4. | Renaissance Technologies Jim Simons | 63,800 | $79,112 | 0% | |
5. | 56,400 | $69,936 | +1780% | 0% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 574,901 | $1,092,312 | 0% | |
2. | 566,650 | $1,076,635 | 0% | |
3. | 516,696 | $981,722 | 0% | |
4. | 313,600 | $595,840 | 0% | |
5. | 310,499 | $589,948 | 0% |